
[ Thu, Jan 09th ]: Forbes
[ Thu, Jan 09th ]: LancasterOnline
[ Thu, Jan 09th ]: scrippsnews
[ Thu, Jan 09th ]: IFLScience
[ Thu, Jan 09th ]: Impacts
[ Thu, Jan 09th ]: techxplore
[ Thu, Jan 09th ]: Techopedia
[ Thu, Jan 09th ]: Forbes
[ Thu, Jan 09th ]: IFLScience
[ Thu, Jan 09th ]: timesnownews
[ Thu, Jan 09th ]: MSN
[ Thu, Jan 09th ]: MSN
[ Thu, Jan 09th ]: MSN
[ Thu, Jan 09th ]: timesnownews
[ Thu, Jan 09th ]: NDTV
[ Thu, Jan 09th ]: MSN

[ Wed, Jan 08th ]: stkate
[ Wed, Jan 08th ]: CNET
[ Wed, Jan 08th ]: techxplore
[ Wed, Jan 08th ]: SETI
[ Wed, Jan 08th ]: Newsday
[ Wed, Jan 08th ]: Forbes
[ Wed, Jan 08th ]: Firstpost
[ Wed, Jan 08th ]: MSN
[ Wed, Jan 08th ]: Tuko
[ Wed, Jan 08th ]: MSN
[ Wed, Jan 08th ]: MSN
[ Wed, Jan 08th ]: BBC
[ Wed, Jan 08th ]: MSN

[ Tue, Jan 07th ]: Indiatimes
[ Tue, Jan 07th ]: TechRadar
[ Tue, Jan 07th ]: NASA
[ Tue, Jan 07th ]: NDTV
[ Tue, Jan 07th ]: Forbes
[ Tue, Jan 07th ]: Forbes
[ Tue, Jan 07th ]: Yahoo
[ Tue, Jan 07th ]: CNET
[ Tue, Jan 07th ]: IFLScience
[ Tue, Jan 07th ]: Yahoo
[ Tue, Jan 07th ]: TradeWinds
[ Tue, Jan 07th ]: MSN
[ Tue, Jan 07th ]: MSN
[ Tue, Jan 07th ]: MSN
[ Tue, Jan 07th ]: MSN
[ Tue, Jan 07th ]: NDTV

[ Mon, Jan 06th ]: MSN
[ Mon, Jan 06th ]: MSN
[ Mon, Jan 06th ]: MSN
Vir jumps after Phase 1 data for Sanofi-partnered cancer drug technology


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data for two antitumor agents developed using its PRO-XTEN masking technology, in-licensed from Sanofi (NASDAQ:SNY).

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biochemistry/vir-jumps-after-phase-1-data-for-sanofi-partnered-cancer-drug-technology/ar-AA1xaULT ]
Similar Science and Technology Publications
[ Mon, Dec 02nd 2024 ]: Tim Hastings